Category Archives: Drug Development
Talking drug prices, Pt 6: Openness vs. secrecy in drug development By Mat Todd
Posted by Drug Development, drug pricing, Ethics, featured, Global Health, open access, open science, open-source, Research Ethics, schistosomiasis, Your Say
inNeglected Tropical Diseases: Challenges for the Post-2015 Development Era
This article is being cross-listed with the Harvard graduate student publication Signal to Noise, Special Edition on Infectious Disease. Health equity is based on the idea that all lives, anywhere in the world, have equal value. Neglected Tropical Diseases (NTDs) are … Continue reading
The post Neglected Tropical Diseases: Challenges for the Post-2015 Development Era appeared first on PLOS Blogs Network.
Posted by development, Drug Development, Global Health, Global Health Systems, Maternal Newborn and Child Health, millennium development goals, Neglected Diseases, neglected tropical diseases, ntds, Parasites, PLoS, PLoS Blogs, PLoS Medicine, PLoS Neglected Tropical Diseases, PLoS Pathogens, post-2015, public health, Rachel Cotton, signal to noise, The Student Blog
in